Patient-reported, health-related quality of life (QOL) metrics that capture elements not always accounted for by traditional scales are increasingly recognized as important measures but are still under-utilized. We studied QOL in a recent cohort of endovascular thrombectomy (EVT) patients. We conducted a multicenter, prospective, observational study of patients treated with EVT. The primary and secondary outcome measures were 90-day EuroQol 5-Dimension 5-Level index (EQ index, scores -0.573 to 1) and the Visual Analog Scale (VAS, 0-100), respectively. Spearman correlation was used to assess correlations between the EQ index and VAS with the 90-day modified Rankin Scale (mRS) and between each EuroQol domain and 90-day mRS. Linear regression was performed to identify factors associated with the outcomes. 212 subjects (mean age 68.4 ± 14.7 years, median NIHSS 15 [interquartile range 10-20]) were included. Mean EQ index was 0.45 ± 0.42 and median VAS was 75 (interquartile range 60-90). Over 40% of subjects reported at slight problems or worse in each QOL domain and nearly 80% reported such problems in at least one domain. EQ index and 90-day mRS were strongly correlated in the full cohort (rs= -0.912, p<0.001) and in survivors (rs= -0.709, p<0.001). In the multiple linear regression analyses, premorbid mRS, cerebral blood volume index, and length of stay appeared to be associated with EQ index and VAS. Ninety-day QOL measures may provide useful information as an adjunct to mRS scoring in selected stroke thrombectomy patients.
Background/Objectives: Recently, a novel CT perfusion (CTP) parameter, the compensation index (COMPI; ratio of 4 s delayed perfusion to 6 s delayed perfusion), was shown to correlate more strongly with digital subtraction angiographic collaterals than the cerebral blood volume index (CBVI) and hypoperfusion intensity ratio. Methods: We retrospectively analyzed all anterior circulation large vessel occlusion patients treated at multiple thrombectomy centers from January to December 2024 to determine the relationship of COMPI and other CTP parameters with the primary outcome: a 90-day modified Rankin Scale (mRS) score of 0–2. Univariable logistic regression was performed to assess the association between each CTP parameter and the primary outcome in the full cohort and in those achieving endovascular reperfusion (modified treatment in cerebral ischemia 2b-3). Multivariable logistic regression was performed to determine factors independently associated with a 90-day mRS score of 0–2. Results: 323 subjects (median age 69 [57–78] years, median of National Institutes of Health Stroke Scale 15 [10–19.5]) were included, of whom 146/302 (48.3%) were functionally independent at 90 days. The COMPI was not associated with the primary outcome in the univariate analysis. CBVI was the only CTP parameter independently associated with a 90-day mRS score of 0–2 in the full cohort (per 0.1-point increase, odds ratio 1.349, 95% confidence interval 1.099–1.655, p = 0.004) and in those achieving reperfusion. Conclusions: The COMPI was not associated with a 90-day mRS score of 0–2. CBVI was associated with independent neurological function in the full cohort and in reperfused patients, supporting its role as a CTP collateral biomarker and potential risk stratification tool before thrombectomy.
Background/Objectives: The Charlotte Large artery occlusion Endovascular therapy Outcome Score (CLEOS) predicts neurological outcomes after endovascular thrombectomy (EVT). Given recent expanded indications for EVT, we evaluated CLEOS in a modern cohort of thrombectomy patients. Methods: We retrospectively analyzed consecutive, anterior circulation EVT patients from January to December 2024 at multiple centers. The primary outcome was a 90-day modified Rankin Scale (mRS) score of 4–6. We compared primary outcome rates between the original CLEOS derivation cohort and the validation cohort. The area under the curve (AUC) was calculated for CLEOS and compared to other prognostic scales. Results: In the 347 included patients, the mean age was 67.6 (14.9) years, the median National Institutes of Health Stroke Scale (NIHSS) was 15 (10–20), and 137 (42.2%) had a 90-day mRS score of 4–6. A similar proportion of patients in the validation cohort and the derivation cohort achieved the primary outcome (39% each, p = 0.957). The AUC for CLEOS (0.7416, 95% confidence interval [CI] 0.688–0.795) was superior to that of the Pittsburgh Response to Endovascular therapy (AUC 0.681, 95% CI 0.624–0.738, p < 0.01) and Stroke Prognostication using Age and NIHSS (AUC 0.5982, 95% CI 0.556–0.640, p < 0.01), while a trend was observed compared to Houston Intra-Arterial Therapy-2 (AUC 0.6999, 95% CI 0.644–0.756, p = 0.0657) and Totaled Health Risk in Vascular Events (AUC 0.7046, 95% CI 0.560–0.759, p = 0.07). CLEOS ≥ 700 predicted the primary outcome in 16/19 (84.2%) patients. Conclusions: CLEOS performed well in our modern cohort of thrombectomy patients. Prognostic scales such as CLEOS may be useful in guiding conversations and setting expectations with family members pre- and post-thrombectomy.
Background/Objectives: Cerebral collateral circulation markers in large core thrombectomy and their impact on functional outcomes have not been extensively reported. Methods: We retrospectively analyzed health system medical records of large core (Alberta Stroke Program Early Computed Tomography Score <6 and/or computed tomography perfusion [CTP] cerebral blood flow <30% volume ≥50 milliliters [mL]) thrombectomy patients over a 19-month period. A good collateral profile (CCC+) was defined as the combination of computed tomography angiography Tan arterial score ≥2 and CTP cerebral blood volume index (CBVI) ≥0.8. A poor profile (CCC−) was defined as Tan <2 and CBVI <0.8. All others were categorized as having a mixed profile (CCC±). Multivariable Firth’s penalized logistic regression was used to identify factors independently associated with the primary outcome, 90-day modified Rankin Scale (mRS) 0–3. Results: 88 patients with median (interquartile range, IQR) age 65.5 (56.5–77.5) years and core volume 78 (55–116) mL were included. Forty-seven patients (53.4%) had poor collateral profiles, 31 (35.2%) were classified as CCC±, and 10 (11.4%) as CCC+. In the multivariable Firth’s penalized logistic regression model, CCC+ patients had higher odds of achieving a 90-day mRS of 0–3 compared with CCC− patients, though the difference was not statistically significant (odds ratio [OR] 1.117, 95% confidence interval [CI] 0.235–5.311, p = 0.889). No significant difference was observed between CCC± and CCC− patients (OR 0.869, 95% CI 0.293–2.577, p = 0.800). Glucose was the only factor independently associated with 90-day outcomes (OR 0.742, 95% CI 0.602–0.915, p = 0.005). Conclusions: No independent association was detected between favorable or mixed cerebral collateral circulation and 90-day mRS 0–3 after large core thrombectomy, though the study was underpowered for the CCC+ comparison. Presenting glucose may inform the likelihood of achieving independent ambulatory status at 90 days.